BCRX BioCryst Pharmaceuticals Inc reports steep Q4 2025 EPS miss stock edges 021 percent lower in daily trading PFE Pfizer Inc posts 143 percent Q4 2025 EPS beat stock rises 125 percent in regular trading EVCM EverCommerce Inc reports Q4 2025 EPS ahead of estimates by nearly 28 percent shares edge higher